Cancer Late Effects: Calls for Better Long-Term Care & Support

Cancer Late Effects: Calls for Better Long-Term Care & Support

March 19, 2026 Nkechi Okonkwo- Health Editor Health

The experience of cancer doesn’t end with treatment. For many, a new set of challenges emerges months or even years later, often referred to as ‘late effects’. A growing movement among clinicians and charities is focused on recognizing and addressing these often-overlooked consequences, particularly for those undergoing pelvic radiotherapy. What we have is especially pertinent for anal cancer, a relatively rare cancer that is receiving increased attention for its impact on quality of life long after initial treatment.

Radiotherapy UK, in partnership with the Belfast Health and Social Care Trust’s Lower GI Clinical Oncology team, is hosting a landmark event on Saturday, March 21st, 2026, to break the silence surrounding anal cancer. The event, marking Anal Cancer Awareness Day, aims to raise awareness, spotlight survivorship and advocate for improved care pathways. It’s a first-of-its-kind gathering in Northern Ireland, and one of a small number globally dedicated solely to this cancer.

The Hidden Impact of Pelvic Radiotherapy

While radiotherapy is a vital tool in treating anal cancer, it can also lead to a range of long-term side effects. These aren’t simply inconveniences. they can profoundly impact a person’s physical and emotional well-being. Sarah Quinlan, of Radiotherapy UK, emphasizes that these “late effects…can emerge months or even years after treatment finishes, significantly affecting quality of life, independence and a person’s well-being.” The goal is to move beyond simply treating the cancer to providing comprehensive, ongoing support.

One patient, Trish, shared her story, illustrating the complexities of navigating life after pelvic radiotherapy. She found that while her GP was supportive during treatment, the system lacked the infrastructure to address the long-term consequences. “During my treatment, my GP was a lifeline, kind and willing to facilitate. But after the treatment ended it became painfully clear that the system wasn’t built to support the complexity of long-term side effects associated with pelvic radiotherapy and I was left to navigate everything alone,” Trish said. Her experience included dealing with incontinence, requiring pads and nappies, and using dilators to manage vaginal tissue changes – all profoundly distressing.

Beyond these immediate physical challenges, Trish also experienced significant changes in her body composition, leading to feelings of disconnect and distress. “My stomach became so swollen from chronic constipation and weight gain that when I looked in the mirror I was looking at someone I no longer recognised,” she recounted. These experiences highlight the demand for a holistic approach to cancer care that acknowledges the lasting impact of treatment.

What are ‘Late Effects’ and Why Do They Matter?

‘Late effects’ encompass a wide range of physical, psychological, and social consequences that can arise after cancer treatment. These effects can vary depending on the type of cancer, the treatment received, and individual factors. For those undergoing pelvic radiotherapy, common late effects include bladder and bowel problems, sexual dysfunction, lymphedema (swelling due to lymphatic system disruption), and chronic pain. Cancer Research UK provides a detailed overview of late effects, emphasizing that they can significantly impact a person’s ability to operate, maintain relationships, and enjoy life.

The challenge lies in the fact that these effects often emerge long after the initial treatment has ended, and patients may not immediately associate them with their cancer history. This can lead to delays in diagnosis and treatment, and a sense of isolation and frustration. Many healthcare professionals lack specialized training in managing late effects, leaving patients to navigate a complex system on their own.

The Call for a Dedicated Late Effects Service

Recognizing this gap in care, Radiotherapy UK is advocating for the development of well-resourced, multidisciplinary late effects services. Quinlan stresses the importance of ensuring patients “don’t feel forgotten about after their treatment ends.” This includes access to specialized medical professionals, such as oncologists, physiotherapists, psychologists, and sexual health specialists, who can provide comprehensive assessment and management of late effects.

The proposed UK’s first anal cancer late effects service, planned for Belfast, represents a significant step forward. This service aims to provide a centralized hub for patients to access specialized care and support, and to conduct research to better understand and manage these long-term consequences. The Belfast Health and Social Care Trust Lower GI Clinical Oncology team is collaborating on this initiative, demonstrating a commitment to improving the lives of those affected by anal cancer.

Understanding Anal Cancer Incidence and Awareness

Anal cancer is considered a relatively rare cancer, representing less than 1% of all colorectal cancers. But, incidence rates have been rising in recent years, particularly among certain populations. According to the Cancer.Net, approximately 9,710 new cases of anal cancer will be diagnosed in the United States in 2024. Risk factors include human papillomavirus (HPV) infection, a history of receptive anal intercourse, and a weakened immune system.

Despite the rising incidence, anal cancer remains shrouded in stigma and silence. This is partly due to the location of the cancer and the sensitive nature of the symptoms, which can include anal pain, bleeding, and itching. This silence can prevent people from seeking early diagnosis and treatment, leading to poorer outcomes. The upcoming event in Northern Ireland is a crucial step towards breaking down these barriers and fostering open conversations about anal cancer.

What’s Next: Building a Comprehensive Care Pathway

The focus now is on building a comprehensive care pathway that extends beyond initial treatment to encompass long-term survivorship. This requires a collaborative effort between healthcare professionals, charities, researchers, and patients. Key steps include:

  • Investing in research to better understand the mechanisms underlying late effects and identify effective interventions.
  • Developing standardized guidelines for the assessment and management of late effects.
  • Training healthcare professionals to recognize and address the unique needs of cancer survivors.
  • Raising public awareness about anal cancer and the importance of early detection and treatment.
  • Ensuring equitable access to specialized care and support for all patients, regardless of their location or socioeconomic status.

The event in Belfast on March 21st, 2026, is not just a one-day occurrence; it’s a catalyst for lasting change. By bringing together key stakeholders and amplifying the voices of those affected by anal cancer, Radiotherapy UK and its partners are paving the way for a future where all cancer survivors receive the comprehensive care and support they deserve.